Gene therapy for inborn error of immunity - current status and future perspectives
{{output}}
Purpose of review: Development of hematopoietic stem cell (HSC) gene therapy (GT) for inborn errors of immunity (IEIs) continues to progress rapidly. Although more patients are being treated with HSC GT based on viral vector medi... ...
